[COX- 2 expression in gastric cancer and its relationship with lymphangiogenesis and lymph node metastasis]

Zhonghua Wei Chang Wai Ke Za Zhi. 2005 Jul;8(4):348-51.
[Article in Chinese]

Abstract

Objective: To investigate the expression of cyclooxygenase-2 (COX-2) and vascular endothelial growth factor-C (VEGF-C) in human gastric cancer, the relationship between their expression and the clinicopathological features,as well as the relationship between these two parameter expression and lymphangiogenesis and lymph node metastasis.

Methods: COX-2 and VEGF-C expressions were detected in 63 gastric cancer samples by immunostaining. Lymphangiogenesis was evaluated by immunostaining with the specific antibody LYVE-1.

Results: The expression rates of COX-2 and VEGF-C were 66.7% (42/63), 52.4% (33/63), respectively in 63 gastric cancer specimens. LYVE-1 was positive in 35 cases (35/63), which indicated lymphangiogenesis in the tumors. The expression of COX-2 was significantly correlated with the expression of VEGF-C, tumor lymphangiogenesis and lymphatic metastasis (P< 0.05), however not gender, tumor size, tumor location, Lauren classification and serosa invasion (P< 0.05).

Conclusions: In gastric cancer, the expression of COX-2 is significantly associated with VEGF-C expression, lymphangiogenesis and lymphatic metastasis. COX-2 may up-regulate the expression of VEGF-C, which induces lymphangiogenesis and accordingly contributes to lymphatic metastasis.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cyclooxygenase 2 / metabolism*
  • Female
  • Humans
  • Lymph Nodes / metabolism
  • Lymph Nodes / pathology*
  • Lymphangiogenesis
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Stomach Neoplasms / metabolism*
  • Stomach Neoplasms / pathology*
  • Vascular Endothelial Growth Factor C / metabolism

Substances

  • VEGFC protein, human
  • Vascular Endothelial Growth Factor C
  • Cyclooxygenase 2
  • PTGS2 protein, human